OpGen (NASDAQ:OPGN) stock is flying high on Monday following results from a study published in a peer-reviewed publication.
Here’s everything potential investors in OPGN stock need to know about today’s news.
Faranak Atrzadeh, chief marketing and scientific affairs officer for OpGen, said this about the news boosting OPGN stock up today.
“Rapid and accurate detection is essential to assess bacterial pneumonia co-infections in critically ill COVID-19 patients. We are pleased about this final data being published as it highlights the strong performance and utility of the Unyvero HPN Panel as a culture-independent comprehensive diagnostic tool to help with detection of bacterial pneumonia earlier in the hospital journey of these patients for more prompt and appropriate treatment.”
OPGN stock was up 74.5% as of Monday morning.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.
The post OPGN Stock: 9 Things for OpGen Investors to Know as Shares Skyrocket appeared first on InvestorPlace.
Seize the market opportunities!
Start trading with a reliable broker.
Let an expert help you get started!
Seize the market opportunities today! Start trading with a safe and reliable broker.
Let's help you get started!